Filing Details

Accession Number:
0001209191-22-060671
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-12 16:02:51
Reporting Period:
2022-12-08
Accepted Time:
2022-12-12 16:02:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822711 Pardes Biosciences Inc. PRDS Pharmaceutical Preparations (2834) 852696306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1884733 P. Sean Brusky C/O Pardes Biosciences, Inc.
2173 Salk Ave., Suite 250, Pmb #052
Carlsbad CA 92008
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-08 21,000 $1.19 21,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually paid ranged from $1.15 to $1.20. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.